Meanwhile, further experiments that include genomic or proteomic analysis are demanded to investigate the mechanism of FERMT1, IL20RB, MET, MMP3, and CARD9 in the progress of PC and verify potential treatment targets. The gene discussed is MET; the disease is pachyonychia congenita.